AI for Pharma & Healthcare 2025

Press Releases

Early detection of increased thrombosis risk

Siemens Healthcare has developed Innovance Antithrombin, a new test for determining congenital and acquired antithrombin deficiency. Insufficient levels of protein in blood can lead to...

Philips leads European“SonoDrugs”project to develop image-guided localized drug...

Royal Philips Electronics today announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment...

Cancer patients in Sweden and Estonia receive faster,...

Installation of the new Elekta Synergy ® systems from Elekta will enable the three university hospitals to begin treating patients with Elekta VMAT (Volumetric Modulated...

Pioneering Cancer Center Introduces Varian RapidArc Treatments for...

Three prostate cancer patients have become the first people in Germany to be treated using a new, faster form of radiotherapy that potentially enables doctors...

BSD-2000 Hyperthermia System Installed at Long Beach Memorial...

BSD Medical Corporation reported that a BSD-2000 hyperthermia system purchased by the Todd Cancer Institute at Long Beach Memorial Medical Center, Department of Radiation Oncology,...

Zoll receives clearance to market new R series...

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...

Ottawa paramedic service awards Zoll a thrid contract...

ZOLL Medical Corporation , a manufacturer of resuscitation devices and elated software solutions, announced today that Ottawa Paramedic Service (OPS), which provides emergency medical services...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »